GMED241220C62500
- 21.88
- 0.000.00%
Globus Medical Newsroom
Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?
Investors in Globus Medical (NYSE:GMED) Have Seen Notable Returns of 58% Over the Past Year
RBC Capital Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $101
Piper Sandler Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $100
Piper Sandler Reaffirms Their Buy Rating on Globus Medical (GMED)
16 Analysts Have This To Say About Globus Medical
Truist Financial Maintains Globus Medical(GMED.US) With Hold Rating, Raises Target Price to $90
Top Picks for 2025 in Healthcare, Consumer, Tech, Industrials, Energy and More
Roth MKM Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $115
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $91
Jefferies Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $100
Globus Medical (GMED) Gets a Buy From Jefferies
CCORF Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $92
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $91
Bone Marrow Aspirate Concentrates Industry Report, Featuring Profiles of 45+ Key Players Including Arthrex, Cesca Therapeutics, Globus Medical, Ranfac, Terumo and Zimmer Biomet Holdings
Wells Fargo Maintains Overweight on Globus Medical, Raises Price Target to $95
Wells Fargo Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $95
ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife
Globus Medical Is Maintained at Buy by Canaccord Genuity
Globus Medical Price Target Raised to $92.00/Share From $85.00 by Canaccord Genuity